IT & Data traineeships

The European Medicines Agency (EMA) is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Masters university student (with a previous degree) who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. 
 
At EMA, traineeships are designed to enhance your knowledge and provide hands-on experience in a dynamic environment. You'll be performing tasks that not only benefit your training but also help you grow professionally. 
 
Only nationals of the EU/EEA are eligible to apply. 
Closing date 6 May 2025 23:59 CET, with intake date (1st day of contract) 1 October 2025. 
 
This year’s opportunities include: 

• Trainee (Network Portfolio governance and stakeholder engagement) 
• Trainee (Digital product designer) 
• Trainee (Agile Transformation & Customer experience) 
• Trainee (Data Analytics and AI Innovation) 
• Trainee (Digital Workplace) 
• Trainee (Computer scientist (research and innovation in health informatics)) 
• Trainee (IRIS Platform) 
• Trainee (Artificial Intelligence for Knowledge Mining in Information Processing and Analytics)
• Trainee (Cloud and Health Information Systems Engineer)  

 
What do we offer: 

A ten-month traineeship at the Agency’s premises in Amsterdam (1 October 2025 - 31 July 2026) 
Stipend: €1,942.19 net per month 
Mentorship 
Career guidance and development 
Social activities: Engage in various social activities to build connections and enjoy your time at EMA. 
2 days of remote work per week 
20 days of paid leaves 

A community and network of trainees from all over the European Union 
More information regarding the traineeship program can be found on our Careers website through this link: https://careers.ema.europa.eu/content/Traineeship/?locale=en_GB Traineeship (europa.eu) 

Would you like to know what are the requirements to apply to a traineeship at EMA? How is the selection process? What to expect if you are selected? 
Do not miss the informative session on the 14th of April 2025.